Global reach.


Support wherever you need us.

Senior expertise.
Agile delivery.


Access to the right experts at the right time.

Intelligent insight.


Evidence-based clarity that cuts through complexity.

About Evohealth

Evohealth is a global life sciences consulting firm delivering solutions for pharmaceutical, biotech and medtech organisations. We bring together in-house experts and a global network of specialists to support strategy, market access and commercial success across the product life cycle.

Our team partners with clients around the world to deliver meaningful impact and better health for all.

WHY THE LIFE SCIENCES SECTOR PARTNERS WITH EVOHEALTH

Health and science are in our DNA – a unique blend of clinical, government and life science experience.

True partnership – collaborative, focused on outcomes that deliver better health for all.
Tailored solutions – no cookie-cutter advice, only fit-for-purpose, bespoke solutions.
Trusted by leaders – trusted across the life sciences sector, as well as government and not-for-profit.
Thought leadership that lasts – award winning white papers and reports that continue to inform, influence and inspire.
Data meets strategy – bridging evidence and execution with rigourous analysis and practical insight.
Commercial and clinical alignment – helping life science leaders turn evidence into action.
End-to-end expertise – delivering rigour and results across the whole product life cycle.

What is Radioligand Therapy?

Radioligand Therapy (RLT) is a form of precision oncology that delivers radiation directly to cancer cells. It works by attaching a radioactive isotope to a ligand that binds to specific targets on tumour cells, allowing healthy tissue to be spared.

Our explainer video provides a clear overview of how RLT works and why it represents a shift in cancer treatment and a step into the future.

Deep Insight. Real Impact.

“At Evohealth we only work on projects that have a demonstrable benefit to patients.”

With more than three decades in health and life sciences, including leading pharmaceutical price negotiations for the Australian government, I founded Evohealth to deliver expert insight and agile execution to clients around the world.

We combine seasoned in-house advisors with a global network of exceptional independent specialists, enabling us to deliver commercially grounded solutions for pharmaceutical, biotech and medtech organisations. This model has earned us long-standing, trusted relationships with clients, who choose to work with us again and again.

Renae Beardmore, Managing Director

“At Evohealth we only work on projects that have a demonstrable benefit to patients.”

Stay informed. Elevate your expertise.

Don’t miss out on vital updates and expert commentary on the health sector.
Subscribe today to our weekly newsletter!

Our projects.

Our projects deliver deep insight, rapid analysis and lasting commercial impact for organisations across life sciences, medtech and the broader health ecosystem. Many of our clients have partnered with us for years and continue to return because of the value we deliver.
Bringing hope to haemophilia patients

Bringing hope to haemophilia patients

AHCDO
Gene therapy is on the horizon as a novel treatment for haemophilia, but its introduction into the Australian healthcare system will be complex.

Data, data everywhere

Data, data everywhere

Understanding how to develop and deliver messages with stakeholders is important for healthcare organisations.

Australian Foundations. Global Responsibility.

Evohealth was founded to deliver better health for all. Supporting efforts to close the gap for Aboriginal and Torres Strait Islander peoples, the world’s oldest continuing culture, is a core part of that mission. We were proud to publish our first Reconciliation Action Plan (RAP) in 2023.

As we grow globally, we carry these values with us, recognising and respecting Indigenous peoples and cultures around the world. We will continue to ensure our work reflects the same commitment to equity, partnership and meaningful impact in every region.

Keen to join our team?

Your Expertise

No Files ChosenAccepted file types: wax, rar, wri. Max. file size: 1 MB

Our clients.

AbbvieAlexionAmgenAstrazenecaBayerBiogenBristol Myers SquibbCooper visionCSLGileadIPASAJohnson & Johnson Innovative MedicineLillyModernaMTP ConnectMSDNovartisNovo NordiskPfizerSanofiTakedaVarian

WHEN NATIONS COMPETE

Why ‘most favoured nation’ matters for medicine access in Australia

While governments worldwide are debating the impact of MFN on medicine access, we have analysed what it means for Australia.

This is the hottest policy topic in life sciences right now — and we’re the first to put it on the agenda in Australia.

Download the MFN report and discover other key insights from Evohealth.

Check your inbox to download report.